QQQ   431.53 (+0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
QQQ   431.53 (+0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
QQQ   431.53 (+0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
QQQ   431.53 (+0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)

TRACON Pharmaceuticals (TCON) News Today

$1.70
-0.10 (-5.56%)
(As of 02:31 PM ET)
SourceHeadline
MarketBeat logoTRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at StockNews.com
americanbankingnews.com - April 16 at 2:22 AM
marketbeat.com logoTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Sees Significant Drop in Short Interest
marketbeat.com - April 11 at 8:03 AM
markets.businessinsider.com logoBuy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation Update
markets.businessinsider.com - April 10 at 7:42 PM
uk.investing.com logoTRACON announces 1-for-20 reverse stock split
uk.investing.com - April 10 at 9:41 AM
investorplace.com logoWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
investorplace.com - April 10 at 6:30 AM
marketbeat.com logo
marketbeat.com - April 10 at 6:04 AM
marketwatch.com logoShares of Tracon Pharmaceuticals Tumble 22% on Reverse Split
marketwatch.com - April 8 at 6:03 PM
finanznachrichten.de logoTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock Split
finanznachrichten.de - April 8 at 1:03 PM
globenewswire.com logoTRACON Pharmaceuticals Announces Reverse Stock Split
globenewswire.com - April 8 at 9:10 AM
MarketBeat logoTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Expected to Post FY2025 Earnings of ($0.27) Per Share
americanbankingnews.com - April 8 at 3:04 AM
MarketBeat logoTRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at StockNews.com
americanbankingnews.com - April 8 at 2:32 AM
markets.businessinsider.com logoBuy Rating Affirmed for TRACON Pharmaceuticals Amid Promising Envafolimab Trial Outlook
markets.businessinsider.com - April 4 at 2:31 AM
msn.com logoTracon Pharma drops after pivotal data for cancer drug
msn.com - April 3 at 4:29 PM
finance.yahoo.com logoTRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned
finance.yahoo.com - April 3 at 8:38 AM
markets.businessinsider.com logoJonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON)
markets.businessinsider.com - March 13 at 7:55 PM
markets.businessinsider.com logoBuy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical Trials
markets.businessinsider.com - March 8 at 1:58 AM
finanznachrichten.de logoTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - March 7 at 3:12 PM
seekingalpha.com logoTRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 7 at 10:12 AM
finance.yahoo.com logoTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 7 at 10:12 AM
globenewswire.com logoTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
globenewswire.com - March 5 at 4:02 PM
msn.com logoTracon Q4 2023 Earnings Preview
msn.com - March 4 at 6:46 PM
benzinga.com logoA Preview Of TRACON Pharma's Earnings
benzinga.com - March 4 at 1:41 PM
globenewswire.com logoTRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
globenewswire.com - February 28 at 4:02 PM
finance.yahoo.com logoTRACON Pharmaceuticals, Inc. (TCON)
finance.yahoo.com - February 13 at 7:14 AM
benzinga.com logoTRACON Pharma Stock (NASDAQ:TCON), Guidance and Forecast
benzinga.com - December 23 at 8:22 AM
markets.businessinsider.com logoBuy Rating for TRACON Pharmaceuticals on Envafolimab’s Promising Trial Outcomes and Strong Market Potential
markets.businessinsider.com - December 21 at 12:02 AM
seekingalpha.com logoTCON TRACON Pharmaceuticals, Inc.
seekingalpha.com - November 25 at 5:51 PM
msn.com logoWhy Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?
msn.com - November 21 at 8:04 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON), Anavex Life Sciences (AVXL) and Genmab (GMAB)
markets.businessinsider.com - November 21 at 1:04 AM
finance.yahoo.com logoTRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
finance.yahoo.com - November 20 at 10:02 AM
markets.businessinsider.com logoPromising Financial and Clinical Prospects Bolster Buy Rating for TRACON Pharmaceuticals
markets.businessinsider.com - November 15 at 6:51 AM
finance.yahoo.com logoTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 12 at 1:27 PM
finanznachrichten.de logoTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - November 10 at 9:16 AM
finance.yahoo.com logoTRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 7:25 PM
msn.com logoTRACON Pharmaceuticals (TCON) Price Target Increased by 21.88% to 6.63
msn.com - November 1 at 3:27 PM
morningstar.com logoTRACON Pharmaceuticals Inc TCON
morningstar.com - November 1 at 10:27 AM
finance.yahoo.com logoTRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023
finance.yahoo.com - October 31 at 6:02 PM
benzinga.com logoWhy Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
benzinga.com - October 27 at 8:32 AM
finance.yahoo.com logoTRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
finance.yahoo.com - September 18 at 10:06 AM
finance.yahoo.com logo7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
finance.yahoo.com - September 2 at 1:25 AM
msn.com logoJonesTrading Downgrades TRACON Pharmaceuticals (TCON)
msn.com - August 22 at 4:28 PM
finance.yahoo.com logoTCON Aug 2023 2.500 call
finance.yahoo.com - August 18 at 4:14 PM
finanznachrichten.de logoTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 16 at 4:34 AM
finance.yahoo.com logoQ2 2023 TRACON Pharmaceuticals Inc Earnings Call
finance.yahoo.com - August 15 at 6:34 PM
finance.yahoo.com logoTRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 14 at 4:35 PM
finance.yahoo.com logoTRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
finance.yahoo.com - August 3 at 10:42 AM
finance.yahoo.com logoTRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
finance.yahoo.com - July 11 at 8:48 AM
msn.com logoWhat's Going On With TRACON Pharmaceuticals Shares Today
msn.com - June 20 at 12:58 PM
finance.yahoo.com logoTRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial
finance.yahoo.com - June 20 at 12:58 PM
finance.yahoo.com logoTRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
finance.yahoo.com - June 16 at 8:30 AM
Get TRACON Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter.

Biden to Launch “FedNOW” [Move Your Money Now] (Ad)

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

TCON Media Mentions By Week

TCON Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TCON
News Sentiment

0.37

0.66

Average
Medical
News Sentiment

TCON News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TCON Articles
This Week

9

1

TCON Articles
Average Week

Get TRACON Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TCON) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners